606 related articles for article (PubMed ID: 31181772)
1. The Evolving Role of CD8
Huff WX; Kwon JH; Henriquez M; Fetcko K; Dey M
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31181772
[TBL] [Abstract][Full Text] [Related]
2. Aging- and Tumor-Mediated Increase in CD8
Huff WX; Bam M; Shireman JM; Kwon JH; Song L; Newman S; Cohen-Gadol AA; Shapiro S; Jones T; Fulton K; Liu S; Tanaka H; Liu Y; Wan J; Dey M
Immunohorizons; 2021 Jun; 5(6):395-409. PubMed ID: 34103370
[TBL] [Abstract][Full Text] [Related]
3. PD1-CD28 Fusion Protein Enables CD4+ T Cell Help for Adoptive T Cell Therapy in Models of Pancreatic Cancer and Non-hodgkin Lymphoma.
Rataj F; Kraus FBT; Chaloupka M; Grassmann S; Heise C; Cadilha BL; Duewell P; Endres S; Kobold S
Front Immunol; 2018; 9():1955. PubMed ID: 30214445
[No Abstract] [Full Text] [Related]
4. 4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy.
Zhang H; Snyder KM; Suhoski MM; Maus MV; Kapoor V; June CH; Mackall CL
J Immunol; 2007 Oct; 179(7):4910-8. PubMed ID: 17878391
[TBL] [Abstract][Full Text] [Related]
5. Immunosenescence: a key player in cancer development.
Lian J; Yue Y; Yu W; Zhang Y
J Hematol Oncol; 2020 Nov; 13(1):151. PubMed ID: 33168037
[TBL] [Abstract][Full Text] [Related]
6. Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent.
Kamphorst AO; Wieland A; Nasti T; Yang S; Zhang R; Barber DL; Konieczny BT; Daugherty CZ; Koenig L; Yu K; Sica GL; Sharpe AH; Freeman GJ; Blazar BR; Turka LA; Owonikoko TK; Pillai RN; Ramalingam SS; Araki K; Ahmed R
Science; 2017 Mar; 355(6332):1423-1427. PubMed ID: 28280249
[TBL] [Abstract][Full Text] [Related]
7. The expression of molecule CD28 and CD38 on CD4⁺/CD8⁺ T lymphocytes in thymus and spleen elicited by Schistosoma japonicum infection in mice model.
Li N; Ji PY; Song LG; Lei JX; Lv ZY; Wu ZD; Shao X; Sun X
Parasitol Res; 2015 Aug; 114(8):3047-58. PubMed ID: 26002824
[TBL] [Abstract][Full Text] [Related]
8. CD8+ CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancers.
Filaci G; Fenoglio D; Fravega M; Ansaldo G; Borgonovo G; Traverso P; Villaggio B; Ferrera A; Kunkl A; Rizzi M; Ferrera F; Balestra P; Ghio M; Contini P; Setti M; Olive D; Azzarone B; Carmignani G; Ravetti JL; Torre G; Indiveri F
J Immunol; 2007 Oct; 179(7):4323-34. PubMed ID: 17878327
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy-induced changes and immunosenescence of CD8+ T-cells in patients with breast cancer.
Onyema OO; Decoster L; Njemini R; Forti LN; Bautmans I; De Waele M; Mets T
Anticancer Res; 2015 Mar; 35(3):1481-9. PubMed ID: 25750301
[TBL] [Abstract][Full Text] [Related]
10. Advancements on phenotypic and functional characterization of non-antigen-specific CD8+CD28- regulatory T cells.
Fenoglio D; Ferrera F; Fravega M; Balestra P; Battaglia F; Proietti M; Andrei C; Olive D; Antonio LC; Indiveri F; Filaci G
Hum Immunol; 2008 Nov; 69(11):745-50. PubMed ID: 18832002
[TBL] [Abstract][Full Text] [Related]
11. The Emerging Role of CD8
Corgnac S; Boutet M; Kfoury M; Naltet C; Mami-Chouaib F
Front Immunol; 2018; 9():1904. PubMed ID: 30158938
[TBL] [Abstract][Full Text] [Related]
12. CD28 costimulation is required for in vivo induction of peripheral tolerance in CD8 T cells.
Vacchio MS; Hodes RJ
J Exp Med; 2003 Jan; 197(1):19-26. PubMed ID: 12515810
[TBL] [Abstract][Full Text] [Related]
13. Impact of cytomegalovirus on early immunosenescence of CD8+ T lymphocytes after solid organ transplantation.
Cantisán S; Torre-Cisneros J; Lara R; Zarraga S; Montejo M; Solana R
J Gerontol A Biol Sci Med Sci; 2013 Jan; 68(1):1-5. PubMed ID: 22552369
[TBL] [Abstract][Full Text] [Related]
14. Shortened telomeres in the expanded CD28-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis.
Effros RB; Allsopp R; Chiu CP; Hausner MA; Hirji K; Wang L; Harley CB; Villeponteau B; West MD; Giorgi JV
AIDS; 1996 Jul; 10(8):F17-22. PubMed ID: 8828735
[TBL] [Abstract][Full Text] [Related]
15. Peripheral human CD8(+)CD28(+)T lymphocytes give rise to CD28(-)progeny, but IL-4 prevents loss of CD28 expression.
Labalette M; Leteurtre E; Thumerelle C; Grutzmacher C; Tourvieille B; Dessaint JP
Int Immunol; 1999 Aug; 11(8):1327-36. PubMed ID: 10421790
[TBL] [Abstract][Full Text] [Related]
16. T helper-independent activation of human CD8+ cells: the role of CD28 costimulation.
Van Gool SW; Zhang Y; Kasran A; de Boer M; Ceuppens JL
Scand J Immunol; 1996 Jul; 44(1):21-9. PubMed ID: 8693288
[TBL] [Abstract][Full Text] [Related]
17. Sustained CD28 expression delays multiple features of replicative senescence in human CD8 T lymphocytes.
Parish ST; Wu JE; Effros RB
J Clin Immunol; 2010 Nov; 30(6):798-805. PubMed ID: 20721608
[TBL] [Abstract][Full Text] [Related]
18. IL-21 sustains CD28 expression on IL-15-activated human naive CD8+ T cells.
Alves NL; Arosa FA; van Lier RA
J Immunol; 2005 Jul; 175(2):755-62. PubMed ID: 16002671
[TBL] [Abstract][Full Text] [Related]
19. Co-Expression of TIGIT and Helios Marks Immunosenescent CD8
Pieren DKJ; Smits NAM; Postel RJ; Kandiah V; de Wit J; van Beek J; van Baarle D; Guichelaar T
Front Immunol; 2022; 13():833531. PubMed ID: 35651622
[TBL] [Abstract][Full Text] [Related]
20. Increased senescent CD8+ T cells in the peripheral blood mononuclear cells of Behçet's disease patients.
Yang JY; Park MJ; Park S; Lee ES
Arch Dermatol Res; 2018 Mar; 310(2):127-138. PubMed ID: 29255925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
